EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 51994PC0293
Amended proposal for a COUNCIL REGULATION (EC) concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists
Amended proposal for a COUNCIL REGULATION (EC) concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists
Amended proposal for a COUNCIL REGULATION (EC) concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists
/* COM/94/293FINAL */
UL C 222, 10.8.1994, p. 16–17
(ES, DA, DE, EL, EN, FR, IT, NL, PT)
Amended proposal for a COUNCIL REGULATION (EC) concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists /* COM/94/293FINAL */
Official Journal C 222 , 10/08/1994 P. 0016
Amended proposal for a Council Regulation (EC) concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists (94/C 222/08) (Text with EEA relevance) COM(94) 293 final (Submitted by the Commission pursuant to Article 189 A (2) of the EC Treaty on 8 July 1994) The Commission presented the above proposal to the Council on 14 October 1993 (1). As a result of the opinion delivered by Parliament at its sitting on 19 April 1994, the original proposal is amended as follows: 1. The following Article is inserted: 'Article 4a The Commission shall examine the feasibility of operating a positive list for the control of chemically synthesized substances that have an anabolic effect and that are intended for use in animals. Substances that form part of the positive list shall be subject to the same control procedures as those described in Article 4 (1).` 2. The following Article is inserted: 'Article 9a Undertakings selling and/or distributing the primary raw materials used in the manufacture of substances having a thyrostatic, oestrogenic, androgenic or gestagenic action, and of beta-agonists, shall be required to keep registers detailing, in chronological order, quantities produced or acquired and those sold or used for the production of pharmaceutical products or veterinary medicines.` 3. The first subparagraph of Article 15 is replaced by the following: 'This Regulation shall enter into force on the day of its publication in the Official Journal of the European Communities.` (1) OJ No C 302, 9. 11. 1993, p. 8.